This synergism was also reflected in the combination’s inhibitory effect on DLBCL cell proliferation, the downregulation of cell cycle-related and antiapoptotic proteins, and the upregulation of proapoptotic proteins and ROS level. The gene discussed is PROS1; the disease is diffuse large B-cell lymphoma.